XML 21 R10.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information
 9 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
We have quantitatively and qualitatively determined that we operate in two operating segments, which are the Sleep and Breathing Health segment and the Residential Care Software segment.
We evaluate the performance of our segments based on net revenues and income from operations. The accounting policies of the segments are the same as those described in note 2 of our consolidated financial statements included in our Form 10-K for the fiscal year ended June 30, 2024. Segment net revenues and segment income from operations do not include inter-segment profits and revenue is allocated to a geographic area based on where the products are shipped to or where the services are performed.
Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate headquarters costs, stock-based compensation, amortization expense from acquired intangibles, restructuring expenses, field safety notification expenses, acquisition related expenses, net interest expense (income), gains and losses attributable to equity method investments, gains and losses on equity investments, and other, net. We neither discretely allocate assets to our operating segments, nor does our Chief Operating Decision Maker evaluate the operating segments using discrete asset information.
Effective in the third quarter of fiscal year 2024, we updated the method of attribution of certain costs that are principally managed at the segment level as part of our evaluation of segment operating performance. As a result, certain costs relating to quality and regulatory assurance, commercial legal, operations, sales and marketing, customer service, information technology, and other administrative costs, which were previously included in Corporate costs within our reconciliation of segment operating profit to income before income taxes, are now reported in segment operating results. The financial information presented herein reflects the impact of the preceding reporting change for all periods presented.
The table below presents a reconciliation of net revenues and net operating profit by reportable segments (in thousands):
Three Months Ended
March 31,		Nine Months Ended
March 31,
2025202420252024
Net revenue by segment
Sleep and Breathing Health$1,130,575 $1,049,023 $3,323,905 $3,029,915 
Residential Care Software161,161 147,957 474,429 432,187 
Total$1,291,736 $1,196,980 $3,798,334 $3,462,102 
Depreciation and amortization by segment
Sleep and Breathing Health$22,818 $21,832 $71,087 $64,307 
Residential Care Software2,251 2,358 6,859 7,843 
Amortization of acquired intangible assets and corporate assets18,606 19,284 56,899 61,042 
Total$43,675 $43,474 $134,845 $133,192 
Net operating profit by segment
Sleep and Breathing Health
$494,796 $456,182 $1,444,492 $1,240,061 
 Residential Care Software (1)
53,179 38,754 149,682 111,846 
Total$547,975 $494,936 $1,594,174 $1,351,907 
Reconciling items
Corporate costs$103,368 $101,336 $307,258 $274,505 
Amortization of acquired intangible assets18,339 19,016 56,093 60,235 
Restructuring expenses— — — 64,228 
Masks with magnets field safety notification expenses (2)
— — — 6,351 
Astral field safety notification expenses (3)
— — — 7,911 
Interest expense (income), net(793)11,026 1,643 39,787 
(Gain) Loss attributable to equity method investments
(335)(440)(2,375)2,716 
Loss on equity investments
5,647 (13,919)7,765 (11,429)
Other, net4,056 2,496 4,277 537 
Income before income taxes$417,693 $375,421 $1,219,513 $907,066 
(1)    During the three and nine months ended March 31, 2024, we recorded $2.0 million of operating lease right-of-use asset impairments within our Residential Care Software segment. The impairments related to leases for office space and were recorded within net operating profit.
(2)    The masks with magnets field safety notification expenses relate to estimated costs to provide alternative masks to patients in response to updated contraindications for use of masks that incorporate magnets.
(3)    The Astral field safety notification expenses relate to estimated costs associated with the replacement of a certain component in some of our Astral ventilation devices that were manufactured between 2013 to 2019.